Indrayani Biotech clarified its recent share price movement, attributing it to market reactions following two recent announcements. The company's Rights Issue Committee is meeting to discuss the ongoing Rights Issue process. Additionally, a board meeting has been announced to discuss the proposal of potentially demerging its food business into a separate company. Management stated no other undisclosed information could influence the share price, emphasizing that movements are market-driven. These updates signal potential capital structure changes and a significant business reorganization for shareholders.